Ameresco to Participate at Upcoming Conferences

FRAMINGHAM, Mass.--(BUSINESS WIRE)-- Ameresco, Inc., (NYSE: AMRC), a leading energy infrastructure solutions provider, today announced that members of its management team will attend the following investor conferences:

• On March 10, 2026, Mark Chiplock, Chief Financial Officer; Leila Dillon, Chief Marketing Officer; and Nicole Bulgarino President of Federal Solutions and Utility Infrastructure at Ameresco, will participate in a panel discussion about U.S. Growth Infrastructure and host investor meetings at the Cantor Global Technology & Industrial Growth Conference at 4:30 p.m. This event will take place at the New York Hilton Midtown in New York, NY.

• On March 24, 2026, George Sakellaris, President and Chief Executive Officer, and Joshua Baribeau, Chief Investment Officer at Ameresco, will host investor meetings at the 38th Annual ROTH Conference. This event will take place at The Ritz-Carlton, Laguna Niguel in Dana Point, CA.

About Ameresco, Inc.

Founded in 2000, Ameresco, Inc. (NYSE: AMRC) is a leading energy infrastructure solutions provider dedicated to helping customers reduce costs, enhance resilience, and decarbonize to net zero in the global energy transition. Our comprehensive portfolio includes implementing smart energy efficiency solutions, upgrading aging infrastructure, and developing, constructing, and operating distributed energy resources. As a trusted full-service partner, Ameresco shows the way by reducing energy use and delivering diversified generation solutions to Federal, state and local governments, utilities, data centers, educational and healthcare institutions, housing authorities, and commercial and industrial customers. Headquartered in Framingham, MA, Ameresco has more than 1,500 employees providing local expertise in North America and Europe. For more information, visit www.ameresco.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260309944533/en/

Media Relations
Leila Dillon, 508.661.2264, [email protected]

Investor Relations
Eric Prouty, Advisiry Partners, 212.750.5800, [email protected]
Lynn Morgen, Advisiry Partners, 212.750.5800, [email protected]

Source: Ameresco, Inc.,

You May Also Be Interested In

• Dr. Reddy’s Announces the First-to-Market Launch of Bosutinib Tablets 400mg, a Generic Equivalent of Bosulif®, in the United States
• 6 Best Crypto Presales as BEAT and VELVET Explode While Retail Hunts the Next Early Runner
• FREELANDER 8 Makes First Public Appearance Ahead of Official Abu Dhabi Launch